|

Multiple Sclerosis Clinical Trials in New Jersey

15 recruiting studies across 14 cities

All Trials in New Jersey

Phase
Trial Phase Location
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—Bridgewater
Multiple Sclerosis Implementation Network (Registry)—Cherry Hill
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple SclerosisN/AEast Hanover
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice—East Hanover
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the CommunityN/AEast Hanover
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2Hackensack
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia—Lawrenceville
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 3Livingston
Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisPhase 4Morristown
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisPhase 3New Brunswick
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1New Brunswick
Gait Adaptation StudyEarly 1Newark
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 3Teaneck
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 3Teaneck
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MSN/AWest Orange

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.